All Stories

  1. Clinical Presentation of a Complex Neurodevelopmental Disorder Caused by Mutations in ADNP
  2. Biallelic intragenic duplication in ADGRB3 (BAI3) gene associated with intellectual disability, cerebellar atrophy, and behavioral disorder
  3. The epilepsy phenotypic spectrum associated with a recurrent CUX2 variant
  4. Next Generation Sequencing expression profiling of mitochondrial subunits in men with Klinefelter syndrome
  5. A genotype-first approach identifies an intellectual disability-overweight syndrome caused by PHIP haploinsufficiency
  6. Searching for new pharmacological targets for the treatment of Alzheimer's disease in Down syndrome
  7. TBC1D24 gene mRNA expression in a boy with early infantile epileptic encephalopathy-16
  8. Hotspots of missense mutation identify neurodevelopmental disorder genes and functional domains
  9. The Methylenetetrahydrofolate Reductase C677T Polymorphism and Risk for Late-Onset Alzheimer’s disease: Further Evidence in an Italian Multicenter Study
  10. Targeted sequencing identifies 91 neurodevelopmental-disorder risk genes with autism and developmental-disability biases
  11. Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform
  12. A polymorphism (rs1042522) in TP53 gene is a risk factor for Down Syndrome in Sicilian mothers
  13. An inflammatory and trophic disconnect biomarker profile revealed in Down syndrome plasma: Relation to cognitive decline and longitudinal evaluation
  14. Low AMH levels as a marker of reduced ovarian reserve in young women affected by Downʼs syndrome
  15. Killer-specific secretory (Ksp37) gene expression in subjects with Down’s syndrome
  16. Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders
  17. Target sequencing approach intended to discover new mutations in non-syndromic intellectual disability
  18. MECP2 missense mutations outside the canonical MBD and TRD domains in males with intellectual disability
  19. Recurrent duplications of 17q12 associated with variable phenotypes
  20. Targeted Next-Generation Sequencing Analysis of 1,000 Individuals with Intellectual Disability
  21. The Koolen-de Vries syndrome: a phenotypic comparison of patients with a 17q21.31 microdeletion versus a KANSL1 sequence variant
  22. Mutations in DDX3X Are a Common Cause of Unexplained Intellectual Disability with Gender-Specific Effects on Wnt Signaling
  23. Response to Phelan K. et al.: Letter to the Editor Regarding Disciglio et al: Interstitial 22q13 deletions not involvingSHANK3gene: A new contiguous gene syndrome
  24. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID
  25. LDOC1 expression in fibroblasts of patients with Down syndrome
  26. Expression of Phosphodiesterase 4B cAMP-Specific Gene in Subjects With Cryptorchidism and Down's Syndrome
  27. NF-kB1 gene expression in Down syndrome patients
  28. Definition of 5q11.2 microdeletion syndrome reveals overlap with CHARGE syndrome and 22q11 deletion syndrome phenotypes
  29. Excess of runs of homozygosity is associated with severe cognitive impairment in intellectual disability
  30. Refining analyses of copy number variation identifies specific genes associated with developmental delay
  31. The transcriptional regulatorADNPlinks the BAF (SWI/SNF) complexes with autism
  32. In utero gene therapy rescues microcephaly caused by Pqbp1-hypofunction in neural stem progenitor cells
  33. Disruptive CHD8 Mutations Define a Subtype of Autism Early in Development
  34. The MTRR 66A>G polymorphism and maternal risk of birth of a child with Down syndrome in Caucasian women: a case–control study and a meta-analysis
  35. Definition of minimal duplicated region encompassing theXIAPandSTAG2genes in the Xq25 microduplication syndrome
  36. Interstitial 22q13 deletions not involving SHANK3 gene: A new contiguous gene syndrome
  37. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP
  38. Increased FGF3 and FGF4 gene dosage is a risk factor for craniosynostosis
  39. Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes
  40. CASP3 protein expression by flow cytometry in Down’s syndrome subjects
  41. The MTR 2756A>G polymorphism and maternal risk of birth of a child with Down syndrome: a case–control study and a meta-analysis
  42. Identification of pathogenic gene variants in small families with intellectually disabled siblings by exome sequencing
  43. 3q29 microdeletion syndrome: Cognitive and behavioral phenotype in four patients
  44. Pericentrin expression in Down’s syndrome
  45. Rapid and accurate large-scale genotyping of duplicated genes and discovery of interlocus gene conversions
  46. The duplication 17p13.3 phenotype: Analysis of 21 families delineates developmental, behavioral and brain abnormalities, and rare variant phenotypes
  47. Phenotypic spectrum and prevalence of INPP5E mutations in Joubert Syndrome and related disorders
  48. Multiplex ligation-dependent probe amplification detection of an unknown large deletion of the CREB-binding protein gene in a patient with Rubinstein-Taybi Syndrome
  49. 6p22.3 deletion: report of a patient with autism, severe intellectual disability and electroencephalographic anomalies
  50. DNMT3B promoter polymorphisms and maternal risk of birth of a child with Down syndrome
  51. KIF21A mRNA expression in patients with Down syndrome
  52. SPAG5 mRNA is over-expressed in peripheral blood leukocytes of patients with Down’s syndrome and cryptorchidism
  53. Gene expression profiling and qRT-PCR expression of RRP1B, PCNT, KIF21A and ADRB2 in leucocytes of Down’s syndrome subjects
  54. Expression of LDOC1 mRNA in leucocytes of patients with Down’s syndrome
  55. A de novo 8q22.2-24.3 duplication in a patient with mild phenotype
  56. Expression of STRBP mRNA in patients with cryptorchidism and Down’s syndrome
  57. PTEN Gene: A Model for Genetic Diseases in Dermatology
  58. Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes
  59. Differential expression of PARP1 mRNA in leucocytes of patients with Down’s syndrome
  60. Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 as a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder
  61. Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/McDermid Syndrome
  62. The Pitt-Hopkins syndrome: Report of 16 new patients and clinical diagnostic criteria
  63. Erratum: The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype
  64. What Syndrome Is This?
  65. Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome
  66. Familial 1.1 Mb deletion in chromosome Xq22.1 associated with mental retardation and behavioural disorders in female patients
  67. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay
  68. Erratum: Corrigendum to: The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype
  69. NovelTMEM67mutations and genotype-phenotype correlates in meckelin-related ciliopathies
  70. Common pathological mutations inPQBP1induce nonsense-mediated mRNA decay and enhance exclusion of the mutant exon
  71. The Clinical Evaluation of Patients with Mental Retardation/Intellectual Disability
  72. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype
  73. ExpandingCEP290mutational spectrum in ciliopathies
  74. Complex Segmental Duplications Mediate a Recurrent dup(X)(p11.22-p11.23) Associated with Mental Retardation, Speech Delay, and EEG Anomalies in Males and Females
  75. Complex Segmental Duplications Mediate a Recurrent dup(X)(p11.22-p11.23) Associated with Mental Retardation, Speech Delay, and EEG Anomalies in Males and Females
  76. Genome rearrangements in patients with blepharophimosis, mental retardation and hypothyroidism, so-called Young-Simpson syndrome
  77. Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome
  78. Fourteen new cases contribute to the characterization of the 7q11.23 microduplication syndrome
  79. SPANX-B and SPANX-C (Xq27 region) gene dosage analysis in Down’s syndrome subjects with undescended testes
  80. MKS3/TMEM67mutations are a major cause of COACH Syndrome, a Joubert Syndrome related disorder with liver involvement
  81. 15q13.3 microdeletions increase risk of idiopathic generalized epilepsy
  82. The molecular landscape of ASPM mutations in primary microcephaly
  83. Inflammatory bowel disease in children and adolescents in Italy: Data from the pediatric national IBD register (1996–2003)
  84. A balanced complex chromosomal rearrangement (BCCR) with phenotypic effect
  85. ERRATA
  86. Cerebriform plantar hyperplasia: the major cutaneous feature of Proteus syndrome
  87. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures
  88. Further Delineation of Deletion 1p36 Syndrome in 60 Patients: A Recognizable Phenotype and Common Cause of Developmental Delay and Mental Retardation
  89. Three new patients with dup(17)(p11.2p11.2) without autism
  90. Identification of non-recurrent submicroscopic genome imbalances: the advantage of genome-wide microarrays over targeted approaches
  91. Bannayan-Riley-Ruvalcaba Syndrome
  92. 12q12 deletion: A new patient contributing to genotype–phenotype correlation
  93. Genetics of Pten Hamartoma Tumor Syndrome (PHTS)
  94. RSK2 enzymatic assay as a second level diagnostic tool in Coffin-Lowry syndrome
  95. Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes
  96. Schizophrenia in a patient with subtelomeric duplication of chromosome 22q
  97. Environmental influence on the worldwide prevalence of a 776C->G variant in the transcobalamin gene (TCN2)
  98. The Italian XLMR bank: a clinical and molecular database
  99. Nail aplasia, microcephaly, severe mental retardation and MRI abnormalities: report of two unrelated cases
  100. Hypersensitivity to Aromatic Anticonvulsants: In Vivo and In Vitro Cross-Reactivity Studies
  101. 2nd International Meeting on Cryptic Chromosomal Rearrangements in Mental Retardation and Autism
  102. 6q Terminal Deletion Syndrome Associated with a Distinctive EEG and Clinical Pattern: A Report of Five Cases
  103. Identification of Novel Mutations in Patients with Coffin-Lowry Syndrome by a Denaturing HPLC-Based Assay
  104. Alopecia areata in Down syndrome: a clinical evaluation
  105. Narrowing the Candidate Region for Congenital Diaphragmatic Hernia in Chromosome 15q26: Contradictory Results
  106. Denaturing HPLC-Based Assay for Detection of ATRX Gene Mutations
  107. Homocysteine and related genetic polymorphisms in Down's syndrome IQ
  108. Skewed X-inactivation in a family with mental retardation and PQBP1 gene mutation
  109. Piezogenic pedal papules during Prader-Willi syndrome
  110. Medial Telangiectatic Sacral Nevi and Mca/Mr Syndromes
  111. Methionine synthase (MTR) 2756 (A → G) polymorphism, double heterozygosity methionine synthase 2756 AG/methionine synthase reductase (MTRR) 66 AG, and elevated homocysteinemia are three risk factors for having a child with Down syndrome
  112. Skewed X chromosome inactivation in carriers is not a constant finding in FG syndrome
  113. Genetic Determinants of Folate and Vitamin B12 Metabolism: A Common Pathway in Neural Tube Defect and Down Syndrome?
  114. A new MRXS locus maps to the X chromosome pericentromeric region: a new syndrome or narrow definition of Sutherland-Haan genetic locus?
  115. Is there a relationship between zinc and the peculiar comorbidities of Down syndrome?
  116. Allele ε4 of apolipoprotein E gene is less frequent in Down syndrome patient of the Sicilian population and has no influence on the grade of mental retardation
  117. Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations
  118. Neuroendocrine features of pubertal development in females with mental retardation
  119. Facial and Skeletal Malformations, Mental Retardation, Aganglionosis, and Neurogenic Muscle Weakness: A Variant of Niikawa-Kuroki Syndrome or a New Syndrome?
  120. Neuroendocrine features of pubertal development in females with mental retardation
  121. Prenatal diagnosis of ATR-X syndrome in a fetus with a new G>T splicing mutation in the XNP/ATR-X gene
  122. Rubinstein–Taybi Syndrome with Epidermal Nevus: A Case Report
  123. Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1
  124. Medial Telangiectatic Sacral Nevi (Types A and C) Associated with Williams Syndrome
  125. PTEN Mutation Spectrum and Genotype-Phenotype Correlations in Bannayan-Riley-Ruvalcaba Syndrome Suggest a Single Entity With Cowden Syndrome
  126. Sulphation deficit in “low-functioning” autistic children: a pilot study
  127. Cardiofaciocutaneous (CFC) syndrome
  128. Progressive Cribriform and Zosteriform Hyperpigmentation: The Late-Onset Feature of Linear and Whorled Nevoid Hypermelanosis Associated with Congenital Neurological, Skeletal and Cutaneous Anomalies
  129. An intriguing case of LEOPARD syndrome.
  130. A gene for FG syndrome maps in the Xq12-q21.31 region
  131. Prevalence of atopic dermatitis in patients with Down syndrome: A clinical survey
  132. LOCALIZED ELASTOSIS PERFORANS SERPIGINOSA IN A BOY WITH DOWN SYNDROME
  133. Saethre-Chotzen syndrome: a clinical, EEG and neuroradiological study
  134. Celiac Disease in Down's Syndrome with HLA Serological and Molecular Studies
  135. CUTANEOUS FINDINGS IN THE MENTALLY RETARDED
  136. Basal body temperature curves and endocrine pattern of menstrual cycles in Down syndrome
  137. Milia-like idiopathic calcinosis cutis: an unusual dermatosis associated with Down syndrome
  138. A CASE OF FG SYNDROME WITH GINGIVAL HYPERPLASIA AND KELOIDS
  139. A further family with epilepsy, dementia and yellow teeth: the Kohlschütter syndrome
  140. SKIN-PICKING: THE BEST CUTANEOUS FEATURE IN THE RECOGNIZATION OF PRADER-WILLI SYNDROME
  141. Phenotypic and phoniatric findings in mosaic cri du chat syndrome
  142. Brain dysfunction and the immune system: Lymphocyte's beta-adrenergic receptor in down syndrome
  143. Molecular analysis of aldolase B genes in hereditary fructose intolerance
  144. Ichthyosis and neutral lipid storage disease